Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer
Status:
NOT_YET_RECRUITING
Trial end date:
2031-12-20
Target enrollment:
Participant gender:
Summary
This study is a single-arm, prospective, phase II clinical study to evaluate the efficacy and safety of preoperative short-course radiotherapy combined with ivonescimab and chemotherapy + total mesorectal excision(TME) surgery in patients with advanced rectal cancer.
Phase:
PHASE2
Details
Lead Sponsor:
The First Affiliated Hospital of Zhengzhou University